Loring Wolcott & Coolidge Fiduciary Advisors LLP Amgen Inc Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$10.5 Billion
Q2 2024

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Amgen Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 65,978 shares of AMGN stock, worth $22.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

65,978

Previous 68,820 4.13%

Holding current value

$22.1 Million

Previous $19.6 Million 5.36%

% of portfolio

0.2%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $746,735 - $907,479	-2,842 Reduced 4.13%	65,978 $20.6 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $547,419 - $660,804	-2,036 Reduced 2.87%	68,820 $19.6 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $233,198 - $263,075	-912 Reduced 1.27%	70,856 $20.4 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $127,472 - $158,261	583 Added 0.82%	71,768 $19.3 Million
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $1.79 Million - $2.12 Million	-8,374 Reduced 10.53%	71,185 $15.8 Million

Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $1.08 Million - $1.32 Million	-4,804 Reduced 5.69%	79,559 $19.2 Million
Q4 2022 Mar 02, 2023	SELL	$229.03 - $291.01 $23,132 - $29,392	-101 Reduced 0.12%	84,363 $22.2 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $1.84 Million - $2.34 Million	-8,051 Reduced 8.7%	84,464 $22 Million
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $46,238 - $52,148	-206 Reduced 0.22%	92,515 $20.9 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $533,170 - $593,326	-2,311 Reduced 2.43%	92,721 $22.6 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $483,490 - $534,866	2,205 Added 2.38%	95,032 $23 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $322,782 - $369,394	1,623 Added 1.78%	92,827 $20.9 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $845,471 - $990,572	3,983 Added 4.57%	91,204 $19.4 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $679,250 - $753,579	2,908 Added 3.45%	87,221 $21.3 Million
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $929,137 - $1.08 Million	4,187 Added 5.23%	84,313 $21 Million
Q4 2020 Jan 14, 2021	SELL	$216.38 - $257.67 $17,094 - $20,355	-79 Reduced 0.1%	80,126 $18.4 Million
Q3 2020 Oct 15, 2020	SELL	$234.65 - $260.95 $348,455 - $387,510	-1,485 Reduced 1.82%	80,205 $20.4 Million
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $52,815 - $64,811	-267 Reduced 0.33%	81,690 $19.3 Million
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $1.11 Million - $1.47 Million	-6,070 Reduced 6.9%	81,957 $16.6 Million
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $1.88 Million - $2.42 Million	9,947 Added 12.74%	88,027 $21.2 Million
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $1.99 Million - $2.38 Million	-11,421 Reduced 12.76%	78,080 $15.1 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $509,601 - $597,368	-3,057 Reduced 3.3%	89,501 $16.5 Million
Q1 2019 Apr 08, 2019	SELL	$180.87 - $203.88 $835,981 - $942,333	-4,622 Reduced 4.76%	92,558 $17.6 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $40,318 - $47,064	-226 Reduced 0.23%	97,180 $18.9 Million
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $18,714 - $21,097	-101 Reduced 0.1%	97,406 $20.2 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $136,991 - $153,870	-825 Reduced 0.84%	97,507 $18 Million
Q1 2018 Apr 20, 2018	BUY	$169.43 - $198.0 $343,434 - $401,346	2,027 Added 2.1%	98,332 $16.8 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $919,905 - $1.03 Million	5,450 Added 6.0%	96,305 $16.7 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $774,050 - $883,757	4,627 Added 5.37%	90,855 $16.9 Million
Q2 2017 Aug 07, 2017	BUY	N/A	86,228	86,228 $0

Others Institutions Holding AMGN

# of Institutions

2,975

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.61M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $179B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account

Loring Wolcott & Coolidge Fiduciary Advisors LLP Amgen Inc Transaction History